We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 759 results
  1. Unveiling the impact of cryptic plasmids curing on Escherichia coli Nissle 1917: massive increase in Ag43c expression

    Escherichia coli Nissle 1917 (EcN) is an important chassis strain widely used for the development of live biotherapeutic products (LBPs). EcN strain...

    Qi Lin, Zhuo Jiang, ... Zuo-ming Nie in AMB Express
    Article Open access 28 April 2024
  2. Growth performance, mucosal immunity and disease resistance in goldfish (Carassius auratus) orally administered with Escherichia coli Strain Nissle 1917

    The current research aimed to shed light on the efficacy of Escherichia coli strain Nissle 1917 (EcN) on goldfish (……) growth, gut immunity,...

    Katayoon Nofouzi, Najmeh Sheikhzadeh, ... Amin Marandi in Fish Physiology and Biochemistry
    Article 22 June 2024
  3. Comprehensive Analysis of the Physiological Characterization of Escherichia coli Nissle 1917

    Escherichia coli Nissle 1917 (EcN) is one of the probiotics that has drawn more attention from researchers in recent days as it extends many host...

    S. Ramadevi, Ruby Shelin, Meenakshi Shanmugaraja in Current Microbiology
    Article 28 March 2023
  4. Inhibition of bacterial swimming by heparin binding of flagellin FliC from Escherichia coli strain Nissle 1917

    Escherichia coli Nissle1917 (EcN) is a non-pathogenic probiotic strain widely used to maintain gut health, treat gastrointestinal disorders, and...

    Guixia Yang, Lingkang Yang, **anxuan Zhou in Archives of Microbiology
    Article 15 July 2023
  5. Development of probiotic E. coli Nissle 1917 for β-alanine production by using protein and metabolic engineering

    Abstract

    β-alanine has been used in food and pharmaceutical industries. Although Escherichia coli Nissle 1917 (EcN) is generally considered safe and...

    Shilong Hu, Mingyue Fei, ... Dongchang Sun in Applied Microbiology and Biotechnology
    Article 16 March 2023
  6. Identification and expression profiling of c-di-GMP signaling genes in the probiotic strain Escherichia coli Nissle 1917 during adhesion to the intestinal epithelial cells

    Cyclic-di-GMP (c-di-GMP) is a ubiquitous signaling molecule in many microorganisms that orchestrates genetic regulation during the transition between...

    Sathyanarayanan Jayashree, Ramamoorthy Sivakumar, ... M. Hussain Munavar in Systems Microbiology and Biomanufacturing
    Article 31 May 2023
  7. High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917

    Background

    Escherichia coli Nissle 1917 (EcN) is a probiotic bacterium used to treat various gastrointestinal diseases. EcN is increasingly being...

    Max van ‘t Hof, Omkar S. Mohite, ... Morten O. A. Sommer in BMC Bioinformatics
    Article Open access 30 December 2022
  8. Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice

    Nattokinase with excellent anti-thrombotic, anti-inflammatory, anti-tumor, and anti-hypertension properties has been used in the development of...

    Manyu Liang, **g Zhang, ... **aowei Gao in World Journal of Microbiology and Biotechnology
    Article 09 November 2022
  9. Improved cryptic plasmids in probiotic Escherichia coli Nissle 1917 for antibiotic-free pathway engineering

    Abstract

    The engineered probiotic Escherichia coli Nissle 1917 (EcN) is expected to be employed in the diagnosis and treatment of various diseases....

    Miao-Miao Dong, Lu Song, ... Feng-Qing Wang in Applied Microbiology and Biotechnology
    Article 05 July 2023
  10. Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer

    Probiotics hold promise as a potential therapy for colorectal cancer (CRC), but encounter obstacles related to tumor specificity, drug penetration,...

    Tuoyu Zhou, **gyuan Wu, ... **angkai Li in npj Biofilms and Microbiomes
    Article Open access 20 January 2024
  11. Adjuvant Effects of Deleting Hypervariable Domains of FliC of Escherichia coli Nissle 1917

    Bacterial flagellin (FliC) can be used as a TLR5 ligand-like adjuvant. However, the sequences of hypervariable regions(HVR) of FliC from different...

    Shuang Li, Yongjun Deng, ... Guilan Wen in Molecular Genetics, Microbiology and Virology
    Article 01 September 2023
  12. Expression of phenylalanine ammonia lyase as an intracellularly free and extracellularly cell surface-immobilized enzyme on a gut microbe as a live biotherapeutic for phenylketonuria

    Phenylketonuria (PKU), a disease resulting in the disability to degrade phenylalanine (Phe) is an inborn error with a 1 in 10,000 morbidity rate on...

    Yu Jiang, Bingbing Sun, ... Sheng Yang in Science China Life Sciences
    Article 28 July 2022
  13. Escherichia coli Nissle 1917 secondary metabolism: aryl polyene biosynthesis and phosphopantetheinyl transferase crosstalk

    Abstract

    Esc herichia col i Nissle 1917 (EcN) is a Gram-negative bacterium that is used to treat inflammatory bowel diseases. The probiotic character...

    Courtney V. Jones, Brianna G. Jarboe, ... Joris Beld in Applied Microbiology and Biotechnology
    Article 21 September 2021
  14. Spectral dynamic causal modelling in healthy women reveals brain connectivity changes along the menstrual cycle

    Longitudinal menstrual cycle studies allow to investigate the effects of ovarian hormones on brain organization. Here, we use spectral dynamic causal...

    Esmeralda Hidalgo-Lopez, Peter Zeidman, ... Belinda Pletzer in Communications Biology
    Article Open access 10 August 2021
  15. The construction of a dual-functional strain that produces both polysaccharides and sulfotransferases

    Objectives

    Heparosan is used as the starting polysaccharide sulfated using sulfotransferase to generate fully elaborate heparin, a widely used...

    **aomei Li, Yanying Yu, ... **anxuan Zhou in Biotechnology Letters
    Article 26 June 2021
  16. High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification

    Abstract

    Heparosan is a naturally occurring non-sulfated glycosaminoglycan. Heparosan serves as the substrate for chemoenzymatic synthesis of...

    Payel Datta, Li Fu, ... Robert J. Linhardt in Applied Microbiology and Biotechnology
    Article 22 January 2021
  17. Metformin-loaded lecithin nanoparticles induce colorectal cancer cytotoxicity via epigenetic modulation of noncoding RNAs

    Background

    Colorectal cancer (CRC) is major aliment around the word, with a cumulative rate of mortality. Metformin (MT) was recently approved as...

    Ahmed A. Abd-Rabou, Ahmed M. Abdelaziz, ... Ghada Ayeldeen in Molecular Biology Reports
    Article 01 September 2021
  18. Heparin stimulates biofilm formation of Escherichia coli strain Nissle 1917

    Objectives

    Escherichia coli strain Nissle 1917 (EcN), a gut probiotic competing with pathogenic bacteria, has been used to attenuate various...

    Dandan Wu, **aomei Li, ... **anxuan Zhou in Biotechnology Letters
    Article 04 October 2020
  19. Structure and biological activity in vitro of Flagellin and its mutants from Escherichia coli Nissle 1917

    Bacterial flagellin is a potent immunomodulatory agent. Previously, we successfully obtained flagellin from Escherichia coli Nissle 1917 (FliC EcN )...

    Shuang Li, Ming Wen, ... Ying Yang in Archives of Microbiology
    Article 18 April 2024
  20. Dual engineered bacteria improve inflammatory bowel disease in mice

    Abstract

    Currently, there are many different therapies available for inflammatory bowel disease (IBD), including engineered live bacterial...

    Yong-Qi Wu, Zhen-** Zou, ... Bang-Ce Ye in Applied Microbiology and Biotechnology
    Article Open access 13 May 2024
Did you find what you were looking for? Share feedback.